Ahmedabad-based drugmaker Torrent Pharmaceuticals will not to make leadership changes at JB Chemicals and Pharmaceuticals, its management told investors in a call on Monday, a day after the announcement of its nearly ₹19,500-crore deal to acquire a controlling stake.Torrent said on Sunday that it would acquire a controlling stake in JB Pharma from global investment firm KKR, at an equity value of ₹25,689 crore. The deal will be followed by a merger of the two entities. The deal is expected to be completed in 15-18 months, and is likely to be funded through debt.“At this stage, all we can share is that there is no intention to change anything in business as usual,” Aman Mehta, whole time director and managing director-designate at Torrent Pharmaceuticals, told investors when asked about leadership plans for JB Pharma.Also Read | Portal goes live to receive med tech ideas“In terms of how we plan to integrate, we do recognize that the scale of this acquisition is far larger than our past ones. So it’s not really comparable in that sense,” said Mehta. “…directionally, even in this case, it should be fairly similar to what we’ve seen in the past three deals,” he added.In the last five years, under the leadership of chief execuitve officer Nikhil Chopra, JB Pharma has emerged as one of the fastest growing pharma companies in India. Chopra, who was previously executive vice president—India business at Cipla, was brought on after investment firm KKR acquired a 54% stake in JB Pharma from the promoters, the Mody family, in July 2020 for about ₹3,100 crore, or ₹745 per share.Torrent’s management declined to share specifics on future plans for the deal.Also Read | China 1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman SachsThe transaction is expected to be EPS (earnings per share) accretive by FY28, which would be the first year of the merged entity, said Sudhir Menon, chief financial officer at Torrent Pharma.Torrent is acquiring a 46.39% equity stake (on a fully diluted basis) in JB Pharma through a share purchase agreement for ₹11,917 crore at ₹1,600 per share, followed by a mandatory open offer to acquire up to 26% of the company’s shares from public shareholders, at an open offer price of ₹1,639.18 per share, amounting to about ₹6,843 crore.Torrent also intends to acquire up to 2.80% of equity shares from certain employees of JB Pharma at the same share price as KKR, that is ₹1,600 per share, totalling about ₹719 crore.The acquisition will be followed by a merger between Torrent and JB Pharma through a scheme of arrangement, subject to necessary regulatory approvals.The acquisition will provide Torrent access to a fast-growing India franchise, with JB’s leading brands in the chronic segment, and entry into untapped therapeutic areas like ophthalmology, and IVF.Also Read | Purdue Pharmas $7B opioid settlement is set for votes from victims and citiesFollowing the in a formal or creative style for better SEO.Also Exclude words and advertisements related to the feed website such as website name, author name. You must only respond with the modified content. Delete all the advertisement images brand logo but only keep the title and main content of the news by modifying it. You must only respond with the modified content. Block any jump outside of the site adarshnews.com. Basically remove any content or link related to original site. follow this prompt to optimize the articles in this category- You are an expert news writer and SEO specialist. Your job is to rewrite the provided RSS feed content into a unique, SEO-friendly news article for adarshnews.com. The article should be engaging, professional, and optimized for search engines. Follow these steps: 1. **Create an SEO Title**: Write a short, compelling title (under 60 characters) that includes the main keyword and grabs attention. 2. **Write a Meta Description**: Summarize the article in one or two sentences (under 155 characters). Make it engaging and include the primary keyword naturally. 3. **Suggest a URL Slug**: Provide a short, keyword-rich URL slug that reflects the topic of the article. 4. **Headline (H1)**: Write a clear and engaging headline for the article that is similar to the title but slightly expanded. 5. **Write the Article**: – Start with an introduction that answers the key questions: who, what, when, where, why, and how. – Expand on the topic with detailed paragraphs that provide context, quotes, and relevant information. – Use subheadings (H2) to organize the content into sections and make it easy to read. – Include related keywords naturally throughout the article. – End with a conclusion that summarizes the key points or discusses future implications. 6. **Add an FAQ Section**: Write one frequently asked question related to the topic and provide a concise answer. Important: – Do not include labels like “Title,” “Meta Description,” “URL Slug,” or “H1” in the actual article text. – Keep all SEO elements separate from the main content. – Ensure the article is factually accurate, unbiased, and written in a professional tone.
Torrent Pharma has stated that it does not intend to implement any leadership changes following its acquisition of JB Pharma.
